HomeCompareEEEND vs JNJ

EEEND vs JNJ: Dividend Comparison 2026

EEEND yields 12578.62% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EEEND wins by $530630960824786880.00M in total portfolio value
10 years
EEEND
EEEND
● Live price
12578.62%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$530630960824786880.00M
Annual income
$522,460,281,137,981,670,000,000.00
Full EEEND calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — EEEND vs JNJ

📍 EEEND pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEEENDJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EEEND + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EEEND pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EEEND
Annual income on $10K today (after 15% tax)
$1,069,182.39/yr
After 10yr DRIP, annual income (after tax)
$444,091,238,967,284,400,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, EEEND beats the other by $444,091,238,967,284,400,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EEEND + JNJ for your $10,000?

EEEND: 50%JNJ: 50%
100% JNJ50/50100% EEEND
Portfolio after 10yr
$265315480412393440.00M
Annual income
$261,230,140,568,990,830,000,000.00/yr
Blended yield
98.46%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

EEEND
No analyst data
Altman Z
44.1
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EEEND buys
0
JNJ buys
0
No recent congressional trades found for EEEND or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEEENDJNJ
Forward yield12578.62%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$530630960824786880.00M$30.5K
Annual income after 10y$522,460,281,137,981,670,000,000.00$4,749.88
Total dividends collected$530089142386534400.00M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EEEND vs JNJ ($10,000, DRIP)

YearEEEND PortfolioEEEND Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$1,268,562$1,257,861.64$10,594$274.49+$1.26MEEEND
2$150,485,867$149,128,505.87$11,294$360.69+$150.47MEEEND
3$16,694,376,373$16,533,356,495.83$12,133$476.91+$16694.36MEEEND
4$1,732,024,490,841$1,714,161,508,122.03$13,156$635.42+$1732024.48MEEEND
5$168,061,214,785,330$166,207,948,580,129.47$14,432$854.61+$168061214.77MEEEND
6$15,252,193,229,276,470$15,072,367,729,456,168.00$16,056$1,162.76+$15252193229.26MEEEND
7$1,294,707,312,727,053,800$1,278,387,465,971,728,000.00$18,175$1,604.53+$1294707312727.04MEEEND
8$102,804,034,285,858,830,000$101,418,697,461,240,890,000.00$21,009$2,252.68+$102804034285858.81MEEEND
9$7,636,149,240,004,887,000,000$7,526,148,923,319,019,000,000.00$24,911$3,229.73+$7636149240004887.00MEEEND
10$530,630,960,824,786,900,000,000$522,460,281,137,981,670,000,000.00$30,458$4,749.88+$530630960824786880.00MEEEND

EEEND vs JNJ: Complete Analysis 2026

EEENDStock

88 Energy Limited explores for oil and gas properties in the United States. It primarily holds a 75% working interest in the Icewine project, which covers an area of approximately 193,000 acres located in North Slope of Alaska, the United States; 100% working interest in the Yukon project covering an area of approximately 38,681 acres situated in the Central North Slope of Alaska; 50% working interest in Peregrine project covering an area of approximately 195,373 acres located in the NPR-A region of the North Slope of Alaska; and 100% working interest in the Umiat Oil Field project covering an area of approximately 17,633 acres situated in the immediate south of Peregrine project North Slope of Alaska. The company was formerly known as Tangiers Petroleum Limited and changed its name to 88 Energy Limited in February 2015. 88 Energy Limited was incorporated in 1996 and is based in Subiaco, Australia.

Full EEEND Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this EEEND vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EEEND vs SCHDEEEND vs JEPIEEEND vs OEEEND vs KOEEEND vs MAINEEEND vs ABBVEEEND vs MRKEEEND vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.